TCT-414 A Novel Drug-Coated Scoring Balloon for the Treatment of Coronary In-Stent Restenosis: Two Years Follow-up Results from the PATENT-C First in Human Trial
Scheller B, Chamié D, Mangner N, Hoffmann S, Bonaventura K, Clever Y, Fontaine T, Costa J, Gershony G, Kelsch B, Kutschera M, Genereux P, Cremers B, Speck U, Abizaid A. TCT-414 A Novel Drug-Coated Scoring Balloon for the Treatment of Coronary In-Stent Restenosis: Two Years Follow-up Results from the PATENT-C First in Human Trial. Journal Of The American College Of Cardiology 2015, 66: b168. DOI: 10.1016/j.jacc.2015.08.428.Peer-Reviewed Original ResearchTreatment of coronary in-stent restenosisCoronary in-stent restenosisYear follow-up resultsFollow-up resultsIn-stent restenosisA novel drug‐coated scoring balloon for the treatment of coronary in‐stent restenosis: Results from the multi‐center randomized controlled PATENT‐C first in human trial
Scheller B, Fontaine T, Mangner N, Hoffmann S, Bonaventura K, Clever Y, Chamie D, Costa R, Gershony G, Kelsch B, Kutschera M, Généreux P, Cremers B, Böhm M, Speck U, Abizaid A. A novel drug‐coated scoring balloon for the treatment of coronary in‐stent restenosis: Results from the multi‐center randomized controlled PATENT‐C first in human trial. Catheterization And Cardiovascular Interventions 2015, 88: 51-59. PMID: 26331782, DOI: 10.1002/ccd.26216.Peer-Reviewed Original ResearchMeSH KeywordsAgedAngioplasty, Balloon, CoronaryBrazilCardiac CathetersCardiovascular AgentsCoated Materials, BiocompatibleCoronary AngiographyCoronary Artery DiseaseCoronary RestenosisFemaleGermanyHumansMaleMetalsMiddle AgedPaclitaxelPercutaneous Coronary InterventionRetreatmentStentsTime FactorsTomography, Optical CoherenceTreatment OutcomeConceptsTarget lesion revascularizationLate lumen lossIn-segment late lumen lossIn-stent restenosisSB groupScoring balloonBare metal stentsAngiographic in-segment late lumen lossCoronary bare metal stentTreatment of in-stent restenosisTreatment of coronary in-stent restenosisRate of binary restenosisCoronary in-stent restenosisAdverse cardiovascular eventsPresence of diabetesFollow-up quantitative coronary angiographyQuantitative coronary angiographyBlinded core labRandomized Controlled TrialsPrimary endpointSecondary endpointsCoronary angiographyMACE rateCardiovascular eventsLesion revascularization
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply